COUMARIN (ESCULETIN) - AN ANTIRHEUMATOID ARTHRITIC COMPOUND: AN UPDATE by S, Jaya Kumari
Vol 11, Special issue 4, 2018
Online - 2455-3891 
Print - 0974-2441
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11s4.31710
COUMARIN (ESCULETIN) - AN ANTIRHEUMATOID ARTHRITIC COMPOUND: AN UPDATE
JAYA KUMARI S*, ANANDHI N, MOUNISHA B, MOHAMED SAMEER MH
Department of Pharmacognosy, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced Studies, 
Pallavaram, Chennai, Tamil Nadu, India. Email: nisajayaa@gmail.com
Context: Esculetin is a natural polyphenolic compound. It is chemically 6,7-dihydroxycoumarin and one of the ingredients of Cortex fraxini, a Chinese 
traditional medicine. It is used as a dietary supplement and found as non-toxic. Recently, there are many research works evaluated on esculetin in 
arthritis with supported molecular mechanisms.
Objectives: Esculetin becoming more attractive prodrug for arthritis. Hence, the present minireview will consolidate the targeted site of esculetin in 
the treatment of arthritis over the past decade.
Results: The most important molecular mechanism of esculetin is an antioxidant activities with decreased level of reactive oxygen species/reactive 
nitrogen species. It also inhibited lipoxygenase 5, lipoxygenase 12, and tyrosinase enzymes. It reduces the inflammation by modulating the key 
inflammatory enzyme matrix metalloproteinase-1 activity. It also lowers the nitrous oxide and prostaglandin E2 level in synovial fluid. Esculetin 
derivatives such as 5-methoxy esculetin inhibited the activity of nitrogen-activated protein kinases. The updated data also reveal that esculetin 
suppresses the leukotriene B4 level in plasma of adjuvant-induced arthritis tested animals.
Conclusion: The presented update showed that esculetin may be useful as a tool in regulating the mechanism and physiological functions of the 
inflammatory mediators and enzyme. Hence, the presented review work may be considered as a scientific proof for the development of an attractive 
drug candidate for the patient with rheumatoid arthritis.
Keywords: Coumarin, Esculetin, Rheumatoid arthritis, Molecular mechanism.
INTRODUCTION
Rheumatoid arthritis (RA) is an autoimmune inflammatory disease. It 
influences around 1% of population. Around 80% of affected patients 
are disabled after 20 years. Economically accessible conventional 
medications are moderate acting and are having restricted adequacy 
and lead to many unwanted symptoms. Moreover, they do not enhance 
the long-term treatment of RA. Esculetin, 6,7-dihydroxycoumarin, is a 
coumarin subordinate found in different plants, Cortex fraxini is one of 
the generally utilized conventional Chinese prescriptions [1]. It has been 
shown that Cortex fraxini has different pharmacological impacts, including 
hostile to pathogenic [2], calming [3], analgesic [4], against malignant 
growth [5], antioxidative activity [6], neuroprotective [7], and vascular 
defensive impacts [8]. It is one of the fundamental dynamic elements 
of Cortex fraxini, has been used as expectorant, against tussive [9] cell 
reinforcement, hostile to bacterial, and hostile to tumor [10]. Particularly, 
esculetin, asculin, fraxin, and fraxetin are found in Cortex fraxini explored as 
major pharmaceutical active ingredients [11]. Esculetin is becoming more 
attractive prodrug for arthritis. Recently, there are many research works 
evaluated on esculetin in arthritis with supported molecular mechanisms. 
Hence, the present minireview will focused to consolidate the targeted site 
of esculetin in the treatment of arthritis over the past decade.
PROFILE OF THE COMPOUND ESCULETIN











•	 Solubility:	 Sparingly	 soluble	 in	water.	Readily	 soluble	 in	methyl	
alcohol





Ethanolic solution of the sample is treated with 0.5 ml of 10% 
ammonium hydroxide solution and examined under UV light. Intense 
fluorescence is observed esculetin form dark brown or black color 
complex with ferric salt.
Pharmacological properties
Anti-inflammatory effect
Esculetin decreases the production of NO to manage blood vessels and 
facilitates the organ tissue destruction swelling; then again, esculetin 
inhibits the production of soluble intercellular adhesion molecule 
(sICAM-1), which can decrease the adhesion reaction of leukocytes 
and endothelial cells in sequence to decrease inflammation [12]. 
Esculetin was found to secure myocardial from ischemia-reperfusion 
damage [13].
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Antitumor effects
Esculetin is a phenolic composite that is found in regular plant items and 
produces apoptosis in various kinds of human malignant growth cells. 
Esculetin has been appeared to specifically produce tumor apoptosis 
in various types of malignant growths and is considered as a promising 
chemotherapeutic agent. Acute promyelocytic leukemia is a kind of disease, 
in which undevelopment cells called promyelocytes multiply uncommon. 
Esculetin is found to restrain the survival of human promyelocytic leukemia 
cells in a fixation ward and time-subordinate way [14,15].
Hepatoprotective effects
Esculetin is found to have against hepatotoxic movement and the 
manifestation of this compound in Cichorium intybus and Bougainvillea 
spectabilis may clarify the folkloric utilization of these plants in liver 
damage [16].
Antidiabetic effects
It was established on the research of Prabakaran, esculetin is 
the treatment and prevention of diabetes mellitus. It can reduce 
hyperglycemia-mediated oxidative stress by antioxidant competence in 
both hepatic and renal tissue [17].
Antibacterial effects
The human pathogen Escherichia coli are spread by direct or indirect 
contact with cause disease in animal and human stools. E. coli is the 
most widely recognized reason for hemorrhagic colitis. The expansion 
of esculetin to human fecal slurries and in vitro non-stop stream 
fermenter models reproducing conditions in the human colon and 
rumen caused checked reductions in the survival of a presented strain 
of E. coli [18].
Antioxidant effects
Esculetin is likewise an intense specialist in cells from reactive oxygen 
species (ROS)-mediated abeta destruction [19]. In another examination, 
esculetin is successful securing cells against DNA injury incited by 
oxidative pressure [16].
Inhibits of the proliferative of vascular smooth muscle cell (VSMC)
The multiplication of VSMCs incited by damage to the intima of supply 
routes is an essential pathogenic factor in vascular proliferative 
disarranges including atherosclerosis and restenosis. Esculetin can 
effectively interfere with the multiplication of rVSMCs in vitro in a 
portion and time-subordinate way [20].
Suppression of Adipogenesis
Esculetin has the impact of advancing glucose digestion and intervenes 
adipocyte apoptosis by the mitochondrial pathway starting the 
apoptotic procedure of 3T3-L1 adipocytes [21]. Another trial showed 
that esculetin has hostile to adipogenic impacts through adjustment 
of	peroxisome	proliferator-activated	receptor	γ	and	CCAAT/enhancer	
binding	 protein	 α	 by	 means	 of	 the	 AMP-activated	 protein	 kinase	
flagging pathway [22].
Table 1: A study report of esculetin on anti‑inflammatory 
potential in arthritis
S. No. Work done
1. Studied effect the newly synthesized mitochondria-targeted 
esculetin for its antiatherosclerotic potential [23]
2. Studied the cell - biotransformation glycoside 
derivatives (esculetin its 6-glycoside esculetin) using 
engineered E. coli and Neisseria polysaccharide 
amylosurase [24]
3. Reported the antiadipogenic activity of esculetin. Through 
the modulation of antioxidant enzymes [25]
4. Assessed pharmacological exercises and compound of 
esculetin and its derivatives [26]
5. The results of their findings shown that the esculetin 
displayed stimulant-like impact which may be identified 
with the restraint of NF-KB pathway and the enactment of 
BNF/Trkb signaling [11]
6. Revealed the potential effectiveness of esculetin in the 
treatment of mental issue with aggravation and oxidative 
pressure [27]
7. Reported (for the 1st time) the 5-methoxy esculetin 
inhibited lipopolysaccharide instigated aggravation 
by smothering MAPK and AP-1 pathway in RAW 264.7 
cells [28]
8. Review work was done on compound, natural exercises, 
and medicinal properties of esculetin and its derivative [29]
9. Investigated defensive impact esculetin in LPS make 
long aggravation might be credit halfway to the restraint 
of NF-KB and RhoA/Rho kinase pathway in vivo and 
in vitro [30]
10. Studied and found out the inhibitory effect of esculetin on 
the coupling exercise of NF-KB and AP-1 in TNF-alpha treat 
vascular smooth muscle cells [31]
11. Isolated coumarin and (herniarin esculetin, scopolin, 
and scopoletin) from Santolina oblongifolia and 
studied inhibitory action of eicosanoid release from 
ionophore-stimulated mouse peritoneal macrophages [32]
12. Studied anti-inflammatory action of benzopyrones by 
inhibition of cyclo- and lipo-oxygenase using croton oil ear 
test in mice [33]
13. Studied anti-inflammatory and peripheral analgesic activity 
of esculetin in animal model [34]
14. Decrease the attachment response of leukocytes and 
additionally endothelial cells keeping in mind the end goal 
to decrease inflammation [35]
15. Diminished the statement of framework MMP-1  
(reduce inflammation) [12]
16. Lowered the nitrous oxide (decrease tissue damage from 
inflammation) and PGE2 level in synovial liquid [36]
17. Protected myocardial from ischemia-reperfusion by 
systemic inflammation [13]
18. Studied antioxidant activities with decreased level of ROS/
RNS (reduced DNA damage), inhibited the lipoxygenase and 
tyrosinase enzymes [37]
PGE2: Prostaglandin E2, MMP-1: Metalloproteinase-1, MAPK: Nitrogen-activated 
protein kinase, ROS/RNS: Reactive oxygen species/reactive nitrogen species, 
NF-KB: Nuclear factor-kappa B, AP-1: Activate or protein-1, BNF: Brain-derived 
neurotrophic factor, Trkb: Tropomyosin-related kinase receptor B, TNF: Tumor 
necrosis factor, E. coli: Escherichia coli
Fig. 2: Chemical structure of esculetin
Fig. 1: 
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Flow diagram for pathogenesis of arthritis
•	 During	sepsis	-	lipopolysaccharide	(a	bacterial	endotoxin)	released	




PGE 2 by synovial cells to cause joint damage in arthritis.
•	 In	patient	with	RA,	 the	 synovial	membrane	 is	 characterized	by	
increased	vascularity,	 infiltration	of	 inflammatory	cells,	primarily	
CD4+T cells.
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DISCUSSION
RA is a common autoimmune inflammatory disease. 80% of affected are 
disabled after 20 years. Rheumatoid joint pain is characterized by expanded 
vascular	invade	of	fiery	cells	-	CD4αT	cells,	which	invigorate	plasma	cells	
to deliver proinflammatory cytokines IL-1, IL-6, and TNF. There are 
many research works around at the UN Food and Drug Administration 
approved drugs for RA the trend today, especially in all industrial settings 
are to seek the bioactive marker that will serve as compound for synthetic 
and semi-synthetic drug development to RA. In this concert, the present 
work an update was done on natural coumarin esculetin - a biomarker 
for the available scientific data in the management of inflammatory 
problem in RA. The most important molecular mechanism of esculetin is 
an antioxidant activity with decreased level of reactive oxygen species/
reactive nitrogen species (ROS/RNS). It also inhibited lipoxygenase 5, 
lipoxygenase 12, and tyrosinase enzymes. It reduces the inflammation 
by modulating the key inflammatory enzyme matrix metalloproteinase-1 
activity. It also lowers the nitrous oxide and prostaglandin E2 level in 
synovial fluid. Esculetin derivatives such as 5-methoxy esculetin inhibited 
the activity of nitrogen-activated protein kinases. The updated data also 
reveal that esculetin suppresses the leukotriene B4 level in plasma of 
adjuvant-induced arthritis tested animals.
CONCLUSION
The presented review data revealed that the selected compound 
was investigated for different inflammatory activities in arthritis. 
Among the updated review of the biological effects and molecular 
mechanisms of esculetin, cell reinforcement action assumes an 
essential part connected with diminished levels of ROS/RNS, which 
is further conceivably identified with the counter proliferative, 
calming, against phospholipids disorder, and other pharmacological 
activities. The presented update showed that esculetin may be useful 
as a tool in regulating the mechanism and physiological functions of 
the inflammatory mediators and enzyme. Hence, the presented review 
work may be considered as a scientific proof for the development of an 
attractive drug candidate for the patient with RA.
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